Biotech Stock 365% This: Big Bet on 3-NDA Strategy
A focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
Overview of annual performance metrics for index funds highlights consistency and risk-adjusted returns to inform choices.
21,807 articlesA focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
Investors watch whether this delay can be offset; honeywell’s stock dropped even as defense orders showed strength. A...
A high-profile rift between two longtime mentors-turned-critics shines a light on how money, branding, and risk manag...
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
The Trump administration is weighing a measure to compensate TSA officers who have gone unpaid during a prolonged par...
A bold HOA reform in Georgia aims to curb excesses, protect buyers, and sharpen lender risk assessments. This could c...
Two strong players define today’s clean energy stock face-off. This guide breaks down how Bloom Energy and Brookfield...
AGNC Investment's dividend yield may catch your eye, but a high number isn’t the whole story. This guide breaks down ...
A growing number of employers are layering cash balance features into 401(K) plans, allowing large annual deferrals f...
USOI, a Credit Suisse X-Links Crude Oil ETN, pays sizable monthly distributions but sits in the risky space of unsecu...
When a high-profile investor shifts a crypto position, the market takes notice. mark cuban says sold most of his Bitc...
MicroStrategy pauses BTC purchases, buys 1.5B face value of 0% notes due 2029 for about $1.38B, and shifts toward a b...